Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M I Saunders

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
The Lancet. Oncology|March 22, 2002
Programming of radiotherapy in the treatment of non-small-cell lung cancer--a way to advance careM I Saunders
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 11, 2002
CHART and chemotherapyM I Saunders
Lung Cancer (Amsterdam, Netherlands)|March 1, 1994
Fractionation and dose in thoracic radiotherapyM I Saunders
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 1, 1991
Is control of the primary tumour worthwhile in non-oat cell carcinoma of the bronchus?M I Saunders
Lung Cancer (Amsterdam, Netherlands)|March 1, 1994
Predictive testing of radiosensitivity in non-small cell carcinoma of the lungM I Saunders
The Oncologist|May 25, 1999
Head and neck cancer: altered fractionation schedulesM I Saunders
The British Journal of Cancer. Supplement|April 1, 1980
Tumour regression and prognosis: a clinical studyS Dische, M I Saunders
International Journal of Radiation Oncology, Biology, Physics|November 1, 1990
Continuous, hyperfractionated, accelerated radiotherapy (CHART) in non-small cell carcinoma of the bronchusM I Saunders, S Dische
British Journal of Cancer|March 1, 1989
Continuous, hyperfractionated, accelerated radiotherapy (CHART)S Dische, M I Saunders
The British Journal of Cancer. Supplement|June 1, 1978
Clinical experience with misonidazoleS Dische, M I Saunders
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
The Lancet. Oncology|March 22, 2002
Programming of radiotherapy in the treatment of non-small-cell lung cancer--a way to advance careM I Saunders
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 11, 2002
CHART and chemotherapyM I Saunders
Lung Cancer (Amsterdam, Netherlands)|March 1, 1994
Fractionation and dose in thoracic radiotherapyM I Saunders
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 1, 1991
Is control of the primary tumour worthwhile in non-oat cell carcinoma of the bronchus?M I Saunders
Lung Cancer (Amsterdam, Netherlands)|March 1, 1994
Predictive testing of radiosensitivity in non-small cell carcinoma of the lungM I Saunders
The Oncologist|May 25, 1999
Head and neck cancer: altered fractionation schedulesM I Saunders
The British Journal of Cancer. Supplement|April 1, 1980
Tumour regression and prognosis: a clinical studyS Dische, M I Saunders
International Journal of Radiation Oncology, Biology, Physics|November 1, 1990
Continuous, hyperfractionated, accelerated radiotherapy (CHART) in non-small cell carcinoma of the bronchusM I Saunders, S Dische
British Journal of Cancer|March 1, 1989
Continuous, hyperfractionated, accelerated radiotherapy (CHART)S Dische, M I Saunders
The British Journal of Cancer. Supplement|June 1, 1978
Clinical experience with misonidazoleS Dische, M I Saunders
Pageof 13